Abstract: Upon treatment of 25(R)-spirost-5-en-3β-ol (diosgenin), 25(R)-1,4,6-spirostatrien-3-one and 25(R)-4,6-spirostadien-3β-ol with 30% H2O2 and 5% NaOH in methanol, diosgenin did not react, 25(R)-1,4,6-spirostatrien-3-one was converted to 25(R)-1α,2α-epoxy-4,6-spirostadien-3-one and 25(R)-4,6-spirostadien-3β-ol was oxidized to give a small amount of 25(R)-4,6-spirostadien-3-one, while most of the original starting material remained unchanged. On the other hand, reactions of diosgenin, 25(R)-1,4,6-spirostatrien-3-one and 25(R)-4,6-spirostadien-3β-ol with m-chloroperoxybenzoic acid in chloroform yielded 25(R)-5α,6α-epoxyspirostan-3β-ol, 25(R)-6α,7α-epoxy-1,4-spirostadien-3-one and 25(R)-4β,5β-epoxy-6-spirosten-3β-ol, respectively.
Introduction
Diosgenin (25(R)-spirost-5-en-3β-ol) is the steroidal saponin which is isolated from the Mexican yam (Dioscorea). Estrogenic, progesterogenic and anti-inflammatory effects have been hypothesized for diosgenin due to its structural similarity to estrogen and progesterone precursors [1] . Diosgenin has been reported to lower serum cholesterol in chicken and rabbits fed cholesterol and to decrease liver cholesterol in cholesterol-fed rats, an action associated with increased rates of cholesterol synthesis, increased secretion of cholesterol into bile acid, and increased fecal excretion of neutral sterols [2] [3] [4] [5] [6] .
Diosgenin was used commercially to produce steroid hormones such as cortisone, estrogen, and progesterone by in vitro chemical modification [7] . 1α-Hydroxydiosgenin and 1β-hydroxydiosgenin (ruscogenin) were used as starting materials in the synthesis of 1α-hydroxycholesterol and 1β-hydroxycholesterol by chemical removal of its side chain [8, 9] . The study showed that 1β-hydroxydiosgenin could be used as a potential starting material for 1α-or 1β-hydroxy vitamin D analogs [10, 11] . Diosgenin was also used as the natural source to synthesize dehydroepiandrosterone (DHEA), a steroid that declines with age, but has significant activities as an antioxidant to modify serum lipid levels and which inhibits proliferation of cancer and noncancer cells in both in vitro and in vivo studies [12] [13] [14] .
Since 1α-or 1β-hydroxydiosgenin is of great interest as a starting material in the synthesis of various active compounds, it is desirable to make hydroxydiosgenin derivatives more available for biological experimentation. The efficient stereoselective synthesis of hydroxydiosgenin derivatives requires a stereoselective epoxidation of double bond as an important intermediate step. Consequently we have examined position selective and reagent selective epoxidations of the olefinic position of diosgenin, 25(R)-1,4,6-spirostatrien-3-one [9] and 25(R)-4,6-spirostadien-3β-ol using 30 % H 2 O 2 and m-chloroperoxybenzoic acid as epoxidizing agents, respectively.
Results and discussion
In this paper, we report the results of a study of the reagent selective and regioselective epoxidation reactions of diosgenin derivatives. The syntheses were accomplished by the procedures described in Scheme 1. 25(R)-Spirost-5-en-3β-ol (diosgenin) was epoxidized with 30% H2O2 and 5% NaOH in methanol, but it did not react, whereas when diosgenin was treated with m-chloroperoxybenzoic acid (mCPBA) in CHCl3 it gave 25(R)-5α,6α-epoxy-spirostan-3β-ol (1) . In this case, the equatorial attack of the mCPBA to the double bond of diosgenin is destabilized by the steric interaction between the reagent and the axial CH3 group (number 19), therefore the downside axial attack is preferred for reagent approach in the transition state. The oxidative dehydrogenation of diosgenin with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone in refluxing 1,4-dioxane gave 25(R)-1,4,6-spirostatrien-3-one (2) . Only the 1,2-double bond of compound 2 was selectively epoxidized with 30% H2O2 and 5% NaOH in methanol to yield 25(R)-1α,2α-epoxy-4,6-spirostadien-3-one (3) [9, 15] . In the absence of directing effects, electrophilic epoxidation of the double bond takes place predominantly from the α-face of the molecule. On the other hand, when compound 2 was epoxidized with mCPBA, 25(R)-6α,7α-epoxy-1,4-spirostadien-3-one (4) was obtained. This result is basically caused by the attack of the mCPBA directed on the less hindered α-face of 6,7-double bond. 25(R)-1,4,6-Spirostatrien-3-one (2) was reduced with NaBH4 in absolute ethanol to give 25(R)-4,6-spirosta-dien-3β-ol (5) [11] . The pπ-electronic system of compound 5 is more stable than 25(R)-1,4-spirostadien-3β-ol [16] . When compound 5 was epoxidized with 30% H2O2 and 5% NaOH in methanol, the 3-hydroxy group was dehydrogenated to yield only 25% of 25(R)-4,6-spirostdien-3-one (6) while most of the original starting material was recovered. In the case of H2O2, epoxidation seems to only occur in the presence of a carbonyl group conjugated with the double bond. Compound 5 was epoxidized with mCPBA to form 25(R)-4β,5β-epoxy-6-spirosten-3β-ol (7) . In this case the presence of the 3β-hydroxy group of the allylic alcohol directed the epoxidation exclusively to the β-face of the double bond of the molecule [16, 17] . All synthesized compounds were identified by IR, 1 H-NMR, 13 C-NMR and mass spectra, respectively.
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Experimental

General
Reactions were performed under nitrogen. 
25(R)-1α,2α-Epoxy-4,6-spirostadien-3-one (3)
. A mixture of 5 % NaOH-MeOH (0.6 mL) and 30 % H2O2 (6 mL) was added to a solution of the trienone 2 (3 g, 7.34 mmol) in methanol (60 mL). The mixture was stirred at room temperature for 22 hours, at which time TLC indicated reaction completion, then extracted with dichloromethane. 
25(R)-6α,7α-epoxy-1,4-spirostadien-3-one (4)
. mCPBA (490 mg, 2.84 mmol) was added to a solution of trienone 2 (1 g, 2.45 mmol) in CHCl 3 (100 mL) at room temperature. The reaction mixture was stirred at the same temperature until no starting material could be detected by TLC. The mixture was stirred with H2O and then extracted with dichloromethane. The extract was dried over MgSO 4 , filtered, and evaporated to give a pale yellow precipitate. Column chromatography on silica gel, eluting with ethyl acetate/n-hexane (1:5) gave the pure white crystals of epoxide 4. (6) . To a solution of compound 5 (500 mg, 1.2 mmol) in methanol (10 mL) was added a mixture of 5 % NaOH-MeOH (0.25 mL) and 30 % H2O2 (0.75 mL) and then it was treated as described for the synthesis of compound 3. Pure compound 6 was obtained as white crystals by column chromatography (ethyl acetate-n-hexane=1:5 
25(R)-4,6-Spirostadien-3-one
